These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10617590)

  • 1. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway.
    Webster K; Parish J; Pandya M; Stern PL; Clarke AR; Gaston K
    J Biol Chem; 2000 Jan; 275(1):87-94. PubMed ID: 10617590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein.
    Brown C; Kowalczyk AM; Taylor ER; Morgan IM; Gaston K
    Virol J; 2008 Jan; 5():5. PubMed ID: 18190682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
    Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
    Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.
    Parish JL; Kowalczyk A; Chen HT; Roeder GE; Sessions R; Buckle M; Gaston K
    J Virol; 2006 May; 80(9):4580-90. PubMed ID: 16611918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cancer cell-specific inducer of apoptosis.
    Green KL; Brown C; Roeder GE; Southgate TD; Gaston K
    Hum Gene Ther; 2007 Jun; 18(6):547-61. PubMed ID: 17572007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
    Roeder GE; Parish JL; Stern PL; Gaston K
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes and is augmented by the HPV-16 E2 protein.
    Ogston P; Raj K; Beard P
    J Virol; 2000 Apr; 74(8):3494-504. PubMed ID: 10729123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
    Massimi P; Pim D; Banks L
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.
    Lee CJ; Suh EJ; Kang HT; Im JS; Um SJ; Park JS; Hwang ES
    Exp Cell Res; 2002 Jul; 277(2):173-82. PubMed ID: 12083799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the HPV-16 E2 transcriptional activator and p53.
    Massimi P; Pim D; Bertoli C; Bouvard V; Banks L
    Oncogene; 1999 Dec; 18(54):7748-54. PubMed ID: 10618715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
    Stubenrauch F; Straub E; Fertey J; Iftner T
    Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
    Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
    J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis.
    Sanchez-Perez AM; Soriano S; Clarke AR; Gaston K
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():3009-18. PubMed ID: 9367388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
    Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
    J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV 16 E2 protein induces apoptosis in human and murine HPV 16 transformed epithelial cells and has antitumoral effects in vivo.
    Bermúdez-Morales VH; Peralta-Zaragoza O; Guzmán-Olea E; García-Carrancá A; Bahena-Román M; Alcocer-González JM; Madrid-Marina V
    Tumour Biol; 2009; 30(2):61-72. PubMed ID: 19390235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins.
    Webster K; Taylor A; Gaston K
    J Gen Virol; 2001 Jan; 82(Pt 1):201-213. PubMed ID: 11125173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy.
    Tan CL; Teissier S; Gunaratne J; Quek LS; Bellanger S
    Cell Cycle; 2015; 14(9):1459-70. PubMed ID: 25789401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
    Thomas M; Matlashewski G; Pim D; Banks L
    Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.